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A B S T R A C T  
 
Background: While it was proven that hemodialysis for treating patients with end stage renal 
disease (ESRD) provided the reduced mortality rate, the reports on its adequacy in the context 
of laboratory parameters and psychological function were limited. Aim: To assess the 
implication of hemodialysis duration on Barthel score and laboratory parameters among ESRD 
patients.  Methods: During the period, a cross-sectional study was conducted at Dr. Soetomo 
General Hospital. Information related to age, gender, history of hypertension, history of 
diabetes mellitus, and the levels of hemoglobin, albumin, calcium, and phosphor were 
retrieved from medical records. While, we performed the interview to each participant using 
Barthel index questionnaire to assess the function independence. We used multiple logistic 
regression analysis to determine the correlation and estimate of effect. Results: We totally 
include we included 65 patients with the hemodialysis duration of more than one year and 16 
patients with the hemodialysis duration of less than one year. Our results found that the higher 
levels of albumin and hemoglobin were observed in patients with hemodialysis duration of 
more than one year. While, the duration of hemodialysis did not affect the Barthel score and 
serum mineral parameters. Conclusion:  The duration of hemodialysis of more than one year 
is associated with the improvement of albumin and hemoglobin levels. 
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I N T R O D U C T I O N  
End stage renal disease (ESRD) remains 
the major health problem worldwide. The 
morbidity of this disease was reported ranging 
from 7.60% to 14.44%,[f] and the mortality was 
reported 5-10 million annually.[2] The morbidity 
of this disease was reported to increase 
approximately 4.77%  in the last two decades, 
and in the next ten years, the morbidity was 
predicted to increase approximately 1.19 to 
1.95%.[3] The managements of ESRD is complex, 
and it consists of renal transplantation and 
dialysis.[4] Of them, hemodialysis is the widest 
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method applied to treat ESRD patients, and it 
was proven that hemodialysis was associated 
with 12%–27% reduced risk of mortality during 
the interval between 1995 and 2013.[5] However, 
some studies have had concerned that the 
implementation of hemodialysis for treating 
ESRD patients was accompanied by some 
issues, the lack of adequacy management.[6-8] 
Moreover, due to ESRD is a chronic disease and 
the treatment for this disease requires 
discipline to routinely control, the 
psychological function of ESRD patients might 
be affected.  
The tools to assess the adequacy of 
hemodialysis treatment among ESRD patients 
either using clinical or laboratory criteria are 
the valuable method to ensure that the adverse 
condition caused by renal impairment does not 
occur. In the context of ESRD, the laboratory 
parameters that might reflect the chronicity of 
the disease including the levels of hemoglobin, 
albumin, and mineral parameters might 
provide the prominent role to assess the 
adequacy of hemodialysis. [6-8] Moreover, the 
psychological function of ESRD patients might 
also play a prominent implication for the 
patients to routinely visit to hemodialysis clinic. 
In some countries such as in India, Korea, and 
Singapore; the psychological function had been 
reported to cause the compliance of ESRD 
patients who routinely visited hemodialysis 
clinic, [9-11] and therefore, psychological function 
of ESRD patients was considered as the pivotal 
factors that should be assessed in ESRD 
patients. In our country, the study reporting 
factors associating with the adequacy of 
hemodialysis patients had never been 
performed before. Therefore, our current study 
aimed to assess the implication of hemodialysis 
duration to the Barthel score and levels of 
hemoglobin, albumin, and mineral parameters 
among ESRD patients.  
M E T H O D S  
Study designs and participants 
A cross-sectional study was conducted 
in Dr. Soetomo General Hospital, Surabaya, 
Indonesia. The target population was all 
hemodialysis patients treated in Dr. Soetomo 
General Hospital during June 2019 to June 
2020. The inclusion criteria were (1) ESRD 
patients treated with hemodialysis in Dr. 
Soetomo General for more than three months 
and the frequency was twice per week, and (2) 
able to communicate in Bahasa Indonesia. 
Patients with one of the following conditions: 
age under 14 years, hemodynamically unstable, 
and having the indication for admission were 
excluded from our study. Information related to 
gender, age, history of hypertension, history of 
diabetes mellitus, duration of hemodialysis, 
and the level of urea, creatinine, calcium, 
phosphor, albumin, and complete blood count 
was extracted from medical record. While, for 
information related to functional status, we 
performed interview in accordance with 
Barthel index.[12] In our present study, a total 
sampling method was used. 
Ethical approval  
The study was approved by the 
Institutional Review Board of Universitas 
Airlangga, Surabaya, Indonesia (No. 
000/XX/XX/2019) in accordance with 
declaration of Helsinki. All subjects had 
provided written informed consent prior to 
participate in this study. All subjects in our 
study were voluntary and we did not provide 
any incentive.  
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Outcome measure 
In our study, the predictor covariate 
was the duration of hemodialysis, divided into 
less than or equal to one year and more than 
one year. While, the outcome measures were 
Barthel score and the levels of calcium, 
phosphor, albumin, and hemoglobin. Those 
laboratory parameters were retrieved from 
medical record (secondary data). 
Statistical Analysis 
The association between the duration 
of hemodialysis and Barthel score and the 
levels of hemoglobin, albumin, calcium, and 
phosphor was analyzed using multiple logistic 
regression analysis. Statistically significant was 
considered if the p value was less than 0.05. We 
used the Statistical Package of Social Sciences 
17.0 software (SPSS Inc., Chicago, IL) to analyze 
the data. 
 
R E S U L T S  
Characteristics of Patients 
A total of 81 hemodialysis patients, we 
enrolled in this study and divided into 65 
patients with the duration of hemodialysis of 
more than one year and 16 patients with less 
than one year, were analyzed. The average age 
was 47.30 and 45.02 years for hemodialysis 
patients with the duration of less than one year 
and more than one year, respectively. Other 
baseline characteristics of the patients such 
gender, the history of hypertension, and the 
history of diabetes mellitus are presented in 
Table 1. The data showed no significant 
different between both groups, indicating that 
the data was presented homogeneously. 
 














Male 50.00 53.73 0.7990 
Hypertension 68.75 56.92 0.3910 
Diabetes mellitus 43.75 20.00 0.0550 
Notes, data were presented in mean ± SD or % 
 
The implication of hemodialysis duration to 
the Barthel score and laboratory 
parameters.  
The average number of Barthel score 
and the levels of calcium, phosphor, albumin, 
and hemoglobin are presented in Table 2. We 
found that the higher levels of hemoglobin and 
albumin were significantly found in 
hemodialysis patients with the duration of 
more than one year compared to less than one 
year (Table 2). While, for other covariates 
including Barthel score and the levels of 
calcium and phosphor, we failed to confirm 
their correlation the duration of hemodialysis.  
Table 2. The summary of Barthel score and laboratory parameters between hemodialysis duration of less than five years and 
more than five years among stage 5 chronic kidney disease patients 
Parameters 
> 1 years 
(n=65) 
≤ 1 years 
(n=16) 
OR 95% CI p 
ADL (Barthel score) 18.48 ± 2.84 18.68 ± 1.49 0.52 0.21-1.34 0.1760 
Phosphor 6.63 ± 3.39 5.26 ± 1.42 2.13 0.35-13.02 0.4130 
Calcium 8.80 ± 1.38 8.78 ± 1.31 1.00 0.16-6.18 1.0000 
Hemoglobin 9.77 ± 1.75 8.81 ± 1.63 2.81 1.08-7.32 0.0340 
Albumin 4.46 ± 2.79 3.58 ± 0.39 16.13 11.85-21.96 <0.0001 
Note, data were presented in mean ± SD; ADL, activities of daily living. 
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D I S C U S S I O N S 
 Our findings showed that, while anemic 
condition was observed in both groups, lower 
hemoglobin levels were found in patients with 
hemodialysis duration of less than one year. 
Our current findings were consistent to the 
previous studies in US, Japan, and Iran. they 
had clarified that shorter duration of 
hemodialysis was correlated to lower levels of 
hemoglobin compared to longer duration of 
hemodialysis among patients with ESRD, and 
the improvement of hemoglobin levels among 
ESRD patients was associated with lower risk of 
mortality.13-15 The underlying causes of our 
findings regarding hemodialysis duration and 
the levels of hemoglobin had not been clearly 
elucidated. However, it was proposed that the 
levels of hemoglobin in patients with ESRD 
might be related to the disease chronicity.16 A 
study revealed that disease chronicity 
remained the prominent factor affecting 
hemoglobin levels, suggesting that renal 
damage might also attribute to the levels of 
hemoglobin.17 Moreover, anemia was reported 
the most common complication of ESRD.18 In 
our present study, longer duration of 
hemodialysis might be related to the 
improvement of renal function and thereafter, 
it might be implicate to the levels of 
hemoglobin.  
 Our results found that normal range of 
albumin levels was observed in both groups, 
however, higher levels of albumin were 
significantly found in patients with the duration 
of hemodialysis more than one year. The 
correlation regarding albumin levels and the 
duration of hemodialysis among ESRD patients 
had been reported by previous studies.19-20 
Previous studies revealed that higher albumin 
levels were found in patients with the duration 
of hemodialysis of more than three years.20-22 
Moreover, studies also revealed that 
hemodialysis was associated with the 
improvement of albumin levels among ESRD 
patients, and the lower levels of albumin was 
found to associate with increased risk of 
mortality.23-25 The lower levels of albumin in 
patients with hemodialysis duration of less 
than one year might be implicated by the 
degree of renal damage, and it might be caused 
by a combination of a reduced synthesis and an 
increased degradation of albumin.26 It has been 
globally proposed that the damage of renal in 
patients with ESRD is irreversible and thereafter 
it  might cause albumin loss through renal and 
subsequently triggers proteinuria and 
decreased levels of albumin in circulation 
among patients with the duration of 
hemodialysis of more than one year,27 
suggesting that renal function improvement 
might be occurred and thereafter, it might 
prevent albumin loss through renal.  
 Unfortunately, our present study failed 
to confirm the correlation between the levels of 
mineral parameters and the duration of 
hemodialysis among ESRD patients. 
Theoretically, the levels of mineral parameters 
together with the levels of hemoglobin and 
albumin should be related to the duration of 
hemodialysis.28 It has been generally known 
that mineral parameters are the indicators of 
chronicity among ESRD patients due to renal 
damage,29 and the longer duration of 
hemodialysis should provide the prominent 
implication to the improvement of renal 
function and thereafter it might provide the 
improvement of mineral parameters. However, 
we failed to clarify the correlation. Further 
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studies are required to reassess the levels of 
mineral parameters and the duration of 
hemodialysis among ESRD patients using 
better study design.  
 Our current study had identified that 
albumin and hemoglobin levels were observed 
better in patients with hemodialysis duration of 
more than one year. Our present results might 
be considered as the initial clues for the 
improvement of renal function among ESRD 
patients treated with hemodialysis for one year 
or more. However, our current findings also 
provided the contradiction, particularly 
regarding the levels of mineral parameters that 
we failed to confirm. Therefore, further studies 
should be performed to elucidate the more 
precise association.  
 Several important limitations were 
observed in our present study. First, the 
potential contributing factors including 
socioeconomic, educational level, and history 
of previous drugs consumption were not 
controlled for.30 Second, our present study 
should cautiously be interpreted due to caution 
duet to relatively small sample size. Third, in 
our present study, we used case-control design, 
and therefore, the probability of bias might 
occur. Additionally, up-coming studies with 
eliminating the limitations of our current study 
might be required to provide the better levels of 
evidence. 
 
C O N C L U S I O N 
Our present study finds that the levels of albumin 
and hemoglobin are observed better in patients with 
hemodialysis duration of more than one year 
compared to less than one year among ESRD 
patients. Our current study may be used as the initial 
clues for assessment of the hemodialysis adequacy 
for ESRD patients treated with hemodialysis for 
more than one year.  
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